These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17493641)

  • 1. Role of G(q) protein in behavioral effects of the hallucinogenic drug 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane.
    Garcia EE; Smith RL; Sanders-Bush E
    Neuropharmacology; 2007 Jun; 52(8):1671-7. PubMed ID: 17493641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen.
    Canal CE; Olaghere da Silva UB; Gresch PJ; Watt EE; Sanders-Bush E; Airey DC
    Psychopharmacology (Berl); 2010 Apr; 209(2):163-74. PubMed ID: 20165943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex.
    Schindler EA; Harvey JA; Aloyo VJ
    Brain Res; 2013 Jan; 1491():98-108. PubMed ID: 23123701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice.
    Smith RL; Barrett RJ; Sanders-Bush E
    Psychopharmacology (Berl); 2003 Feb; 166(1):61-8. PubMed ID: 12474110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice.
    Niimi K; Takahashi E; Itakura C
    Exp Anim; 2010; 59(4):441-7. PubMed ID: 20660990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
    Lee MY; Chiang CC; Chiu HY; Chan MH; Chen HH
    Neuropharmacology; 2014 Jun; 81():215-23. PubMed ID: 24534112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The serotonin 5-HT(2A) receptor agonist TCB-2: a behavioral and neurophysiological analysis.
    Fox MA; French HT; LaPorte JL; Blackler AR; Murphy DL
    Psychopharmacology (Berl); 2010 Sep; 212(1):13-23. PubMed ID: 19823806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of Galpha11 protein contributes to agonist-induced desensitization of 5-HT2A receptor signaling.
    Shi J; Zemaitaitis B; Muma NA
    Mol Pharmacol; 2007 Jan; 71(1):303-13. PubMed ID: 17056873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral effects of (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane, (DOI) in the elevated plus-maze test.
    Onaivi ES; Bishop-Robinson C; Darmani NA; Sanders-Bush E
    Life Sci; 1995 Nov; 57(26):2455-66. PubMed ID: 8847967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic treatment with LY341495 decreases 5-HT(2A) receptor binding and hallucinogenic effects of LSD in mice.
    Moreno JL; Holloway T; Rayannavar V; Sealfon SC; González-Maeso J
    Neurosci Lett; 2013 Mar; 536():69-73. PubMed ID: 23333599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.
    Moreno JL; Holloway T; Albizu L; Sealfon SC; González-Maeso J
    Neurosci Lett; 2011 Apr; 493(3):76-9. PubMed ID: 21276828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative phosphoproteomics unravels biased phosphorylation of serotonin 2A receptor at Ser280 by hallucinogenic versus nonhallucinogenic agonists.
    Karaki S; Becamel C; Murat S; Mannoury la Cour C; Millan MJ; Prézeau L; Bockaert J; Marin P; Vandermoere F
    Mol Cell Proteomics; 2014 May; 13(5):1273-85. PubMed ID: 24637012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.
    González-Maeso J; Weisstaub NV; Zhou M; Chan P; Ivic L; Ang R; Lira A; Bradley-Moore M; Ge Y; Zhou Q; Sealfon SC; Gingrich JA
    Neuron; 2007 Feb; 53(3):439-52. PubMed ID: 17270739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences across sexes on head-twitch behavior and 5-HT
    Jaster AM; Younkin J; Cuddy T; de la Fuente Revenga M; Poklis JL; Dozmorov MG; González-Maeso J
    Neurosci Lett; 2022 Sep; 788():136836. PubMed ID: 35963476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. D-serine deficiency attenuates the behavioral and cellular effects induced by the hallucinogenic 5-HT(2A) receptor agonist DOI.
    Santini MA; Balu DT; Puhl MD; Hill-Smith TE; Berg AR; Lucki I; Mikkelsen JD; Coyle JT
    Behav Brain Res; 2014 Feb; 259():242-6. PubMed ID: 24269270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A genetic screen for mouse mutations with defects in serotonin responsiveness.
    Weiss KC; Kim DY; Pawson CT; Cordes SP
    Brain Res Mol Brain Res; 2003 Jul; 115(2):162-72. PubMed ID: 12877987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased behavioral and neuronal responses to a hallucinogenic drug in PACAP heterozygous mutant mice.
    Hazama K; Hayata-Takano A; Uetsuki K; Kasai A; Encho N; Shintani N; Nagayasu K; Hashimoto R; Reglodi D; Miyakawa T; Nakazawa T; Baba A; Hashimoto H
    PLoS One; 2014; 9(2):e89153. PubMed ID: 24586556
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex.
    Pierce PA; Peroutka SJ
    Psychopharmacology (Berl); 1989; 97(1):118-22. PubMed ID: 2540505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex.
    González-Maeso J; Yuen T; Ebersole BJ; Wurmbach E; Lira A; Zhou M; Weisstaub N; Hen R; Gingrich JA; Sealfon SC
    J Neurosci; 2003 Oct; 23(26):8836-43. PubMed ID: 14523084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.